Non-alcoholic steatohepatitis registry platform study

Trial Identifier: D1843R00356
Sponsor: AstraZeneca
Start Date: November 2023
Primary Completion Date: October 2025
Study Completion Date: October 2025

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
China Changchun, China
China Chengdu, China
China Fuzhou, China
China Inner Mongolia, China
China Nanchang, China
China Qingdao, China
China Taiyuan, China
China Tianjin, China
China Wenzhou, China
China Zhengzhou, China